You are here: Industry Insights > monoclonal antibody

News List

Eisai, UCL commence phase I clinical studies for anti-tau monoclonal antibody expressbpd
December 10, 2018
Eisai, UCL commence phase I clinical studies for anti-tau monoclonal antibody
Darzalex Phase 3 Study Shows Efficacy and Safety Data of Anti-CD38 Monoclonal Antibody in Patients with Newly Diagnosed Multiple Myeloma americanpharmaceuticalreview
December 06, 2018
The Janssen Pharmaceutical Companies of Johnson & Johnson announced results from the Phase 3 MAIA study demonstrating that the addition of daratumumab to....
Tychan Completes Human Safety Studies for Monoclonal Antibody against Zika americanpharmaceuticalreview
October 30, 2018
Tychan has successfully completed Phase-1 safety trials for Tyzivumab, its first-in-class monoclonal antibody (mAb) therapeutic for Zika, in Singapore.
Jobs and Elon Musk in the Life Sciences Community? Stephen Hoge will Disrupt the Entire Monoclonal Antibody Industry with mRNA Therapy Chen Bin
September 21, 2018
Stephen Hoge will Disrupt the Entire Monoclonal Antibody Industry with mRNA Therapy
Atreca bags $125M as solid tumor trial comes into view fiercebiotech
September 13, 2018
Atreca’s cranking of its discovery engine has uncovered more than 1,000 antibodies.
Y-mAbs preps $92M IPO to push lead assets through regulatory filing fiercebiotech
August 28, 2018
Naxitamab and omburtamab are in pivotal phase 2 studies for relapsed/refractory high-risk neuroblastoma and central nervous system/leptomeningeal metastases from neuroblastoma, respectively. (Y-mAbs Therapeutics)
I-Mab Biopharma, MorphoSys declares China IND Submission of monoclonal antibody biospectrumasia
August 10, 2018
The company has Submitted an investigational new drug (IND) application to China National Drug Administration (CNDA) for TJ202/MOR202, a human monoclonal antibody directed against CD38 for the treatment of multiple myeloma.
Which of the Blockbuster Drugs on the Autoimmune Drug Market Will Show the Glory that Humira Had?(5) Siyi
June 11, 2018
TNFα inhibitors have made brilliant achievements since the launch of the first relevant monoclonal antibody...
Which of the Blockbuster Drugs on the Autoimmune Drug Market Will Show the Glory that Humira Had?(3) Siyi
June 08, 2018
Among other autoimmune diseases, anti-IL-12/23 Stelara does not have advantages over TNFα inhibitors...
The Most Comprehensive Summary Ever! About the Chinese-produced Anti-PD-1/PD-L1 Drugs Caicai
April 13, 2018
The anti-PD-1 monoclonal antibody JS001 of Junshi has been completed the first patient administration of Phase I clinical trial in the U.S. several days ago, which has aroused wide attention from the insiders.

Previous page 1 2 3 4 5 6 Next page